USTEKINUMAB-AAUZ
Generic: ustekinumab-aauz
- Manufacturer
- Amgen
- NDC
- 65219-862
- RxCUI
- 2702606
- Route
- SUBCUTANEOUS
- ICD-10 indication
- L40.0
Affordability Check
How much will you actually pay for USTEKINUMAB-AAUZ?
In 30 seconds, see every legitimate way to afford USTEKINUMAB-AAUZ — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
About USTEKINUMAB-AAUZ
What is this medication? Ustekinumab-aauz is a prescription biologic medication used to treat several chronic inflammatory conditions. It is classified as a biosimilar, which means it is highly similar to an original biological product already approved by the FDA. This medication is primarily used for adults and children with moderate to severe plaque psoriasis who may benefit from systemic therapy or phototherapy. It is also indicated for the treatment of active psoriatic arthritis in adults to help manage joint swelling and improve physical movement.
Beyond skin and joint issues, this medication is also prescribed for adults living with moderate to severe Crohn's disease or ulcerative colitis. It functions by inhibiting two specific proteins, interleukin-12 and interleukin-23, which are involved in the body's inflammatory and immune responses. By interfering with these pathways, the drug helps to decrease inflammation in the intestines and on the skin surface. The treatment typically begins with an intravenous infusion and continues with regular subcutaneous injections.
Copay & patient assistance
- Patient Copay Amount: As little as $0 per month
- Maximum Annual Benefit Limit: Not Publicly Available (Note: Text confirms an annual maximum exists but does not state the specific dollar amount)
- Core Eligibility Restrictions: Patients must have commercial or private insurance. Patients are not eligible if the prescription is eligible to be reimbursed, in whole or in part, by any state or federal healthcare program (e.g., Medicare, Medicaid).
- RxBIN, PCN, and Group numbers: Not Publicly Available
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for ustekinumab-aauz.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup USTEKINUMAB-AAUZ →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for ustekinumab-aauz →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Conditions we've indexed resources for
Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.
Medicare Part D coverage
How USTEKINUMAB-AAUZ appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).
Covered by plans
3%
167 of 5,499 plans
Most common tier
Tier 3
On 68% of covering formularies
Prior authorization required
100%
of covering formularies
| Tier | Formularies on this tier | Share |
|---|---|---|
| Tier 1 (preferred generic) | 17 | 27% |
| Tier 2 (generic) | 3 | 5% |
| Tier 3 (preferred brand) | 43 | 68% |
Step therapy: 0% of formularies
Quantity limits: 21% of formularies
Coverage breadth: 63 of 65 formularies
How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
Related drugs
Otulfi
Same generic · ustekinumab-aauz
Duobrii
Treats same condition · halobetasol propionate and tazarotene
Calcipotriene
Treats same condition · calcipotriene
Oxygen/Nitrogen 40/60
Treats same condition · Oxygen/Nitrogen 40/60
INDOMETHACIN
Treats same condition · Indomethacin
Diflunisal
Treats same condition · Diflunisal
Diclofenac DR
Treats same condition · Diclofenac
Trionex
Treats same condition · Calcipotriene Cream, 0.005% and Transparent Dressing
Rowasa
Treats same condition · mesalamine
Physician EZ Use Joint Tunnel and Trigger Kit
Treats same condition · AMMONIA, LIDOCAINE HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, POVIDONE-IODINE
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.